{"transactions":[{"id":799997,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-04-27T20:27:53.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":1641,"price":5.204,"value":8539.764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":188671,"source":{"system":"sec-edgar","filing":"0000905148-26-001865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001865/form4.xml","form_type":"4"}},{"id":834758,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:39.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":2816,"price":5.245,"value":14769.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":190312,"source":{"system":"sec-edgar","filing":"0000905148-26-001382","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001382/form4.xml","form_type":"4"}},{"id":931085,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-27T00:49:14.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":86500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":193128,"source":{"system":"sec-edgar","filing":"0000905148-26-000357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000357/form4.xml","form_type":"4"}},{"id":934095,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-21T21:05:27.000Z","date":"2026-01-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3390,"price":2.1,"value":7119.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":106628,"source":{"system":"sec-edgar","filing":"0000905148-26-000282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000282/form4.xml","form_type":"4"}},{"id":939949,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-13T22:21:47.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3950,"price":1.93,"value":7623.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":110018,"source":{"system":"sec-edgar","filing":"0000905148-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000164/form4.xml","form_type":"4"}},{"id":1203535,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:54:51.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":39500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0000905148-25-000941","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000941/form4.xml","form_type":"4"}},{"id":1203534,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2025-03-18T00:54:51.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":113968,"source":{"system":"sec-edgar","filing":"0000905148-25-000941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000941/form4.xml","form_type":"4"}},{"id":1280167,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2025-02-06T21:37:16.000Z","date":"2025-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":8190,"price":1.14,"value":9336.6,"ownership":{"direct":true},"balance_after":74468,"source":{"system":"sec-edgar","filing":"0000905148-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000403/form4.xml","form_type":"4"}},{"id":1674071,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-22T23:01:02.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter."}],"balance_after":60000,"derivative":{"exercise_price":2.77,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-24-003191","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036124003191/form4.xml","form_type":"4"}},{"id":1674070,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2024-01-22T23:01:02.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024."}],"balance_after":82658,"source":{"system":"sec-edgar","filing":"0001140361-24-003191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036124003191/form4.xml","form_type":"4"}},{"id":1679866,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2024-01-12T21:17:21.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3950,"price":3.265,"value":12896.75,"ownership":{"direct":true},"balance_after":42658,"source":{"system":"sec-edgar","filing":"0001140361-24-002128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036124002128/form4.xml","form_type":"4"}},{"id":2055510,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-12T22:30:17.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":69912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 17,478 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter."}],"balance_after":69912,"derivative":{"exercise_price":3.5,"expiration_date":"2033-01-09","underlying":"Common Stock","underlying_shares":69912},"source":{"system":"sec-edgar","filing":"0001140361-23-001508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123001508/form4.xml","form_type":"4"}},{"id":2055509,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2023-01-12T22:30:17.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":46608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023."}],"balance_after":46608,"source":{"system":"sec-edgar","filing":"0001140361-23-001508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123001508/form4.xml","form_type":"4"}},{"id":2419031,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-01T21:23:00.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest with respect to 12,500 shares on January 28, 2023, and then with respect to 1,041 shares on the last day of each month from February 2023 through December 2025 and with respect to 1,065 shares at the end of January 2026."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-22-003492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122003492/form4.xml","form_type":"4"}},{"id":2979518,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-11-16T23:31:26.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1,562 shares vest each month-end from November 2020 through October 2024."}],"balance_after":75000,"derivative":{"exercise_price":4.05,"expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-20-025729","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120025729/form4.xml","form_type":"4"}}]}